Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Quick Heal Technologies Limited (QUICKHEAL.NS)
Pune, IN
Quick Heal Technologies Limited, an Indian company established in Pune in 1995, specializes in providing cybersecurity software and solutions. The firm caters to a diverse clientele, including individual consumers, small and medium-sized businesses, government bodies, and large corporations, serving both the domestic Indian market and international clients. Its business is divided into three key operating segments: Retail, Enterprise & Government, and Mobile. Among its core product offerings are GoDeep.AI, an advanced engine for detecting malware; Seqrite Hawk, a comprehensive cybersecurity platform; and Hawk Eye, a sophisticated cloud-based platform designed for centralized enterprise security management. Quick Heal also delivers vital technical and post-sales support services. Its products, all branded under Seqrite, reach customers through an extensive network of service providers, system integrators, resellers, and distributors.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -1.28% | -4.69% | +19.99% | +16.34% | -34.38% | -26.55% | -32.42% | +40.53% | -16.46% | -14.48% | -23.10% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Software - Application: +13.0%-6.6% Q1'26: -25.2% (vs Q1'25)
-
EPS growth Software - Application: +28.6%-320.0% Q1'26: -496.7% (vs Q1'25)
-
FCF margin FCF growth · Software - Application: +45.3%+0.8% Q1'26: -39.0% (vs Q1'25)
-
EBIT margin Software - Application: +9.4%-16.6% Q1'26: -68.5% (vs Q1'25)
-
ROIC Software - Application: +7.5%-19.8% Q1'26: -41.1% (vs Q1'25)
-
Share dilution Software - Application: +0.0%-1.4% ★ Q1'26: +2.8% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Software - Application: -1.16×0.00× Q1'26: 0.00× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Mar 2017 actual |
Mar 2018 actual |
Mar 2019 actual |
Mar 2020 actual |
Mar 2021 actual |
Mar 2022 actual |
Mar 2023 actual |
Mar 2026 1 Rev. Ana. 1 EPS Ana. |
Mar 2027 1 Rev. Ana. 1 EPS Ana. |
Mar 2028 1 Rev. Ana. 1 EPS Ana. |
Mar 2029 1 Rev. Ana. 1 EPS Ana. |
Mar 2030 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
3.00B
est: 3.47B (-13.6%)
|
3.18B
est: 3.16B (+0.7%)
|
3.15B
est: 5.28B (-40.3%)
|
2.86B
est: 3.32B (-13.7%)
|
3.33B
est: 3.62B (-7.9%)
|
3.42B
est: 3.84B (-11.0%)
|
2.78B
est: 4.08B (-31.9%)
|
3.47B
3.47B – 3.47B
-15.0% YoY
|
3.16B
3.16B – 3.16B
-8.9% YoY
|
5.28B
5.28B – 5.28B
+67.0% YoY
|
3.32B
3.32B – 3.32B
-37.1% YoY
|
3.62B
3.62B – 3.62B
+9.0% YoY
|
| EBITDA |
906.85M
est: 648.87M (+39.8%)
|
1.21B
est: 590.90M (+104.3%)
|
1.28B
est: 986.77M (+30.0%)
|
916.42M
est: 620.21M (+47.8%)
|
1.45B
est: 1.60B (-9.4%)
|
1.07B
est: 1.70B (-37.1%)
|
227.70M
est: 767.37M (-70.3%)
|
648.87M
648.87M – 648.87M
-15.4% YoY
|
590.90M
590.90M – 590.90M
-8.9% YoY
|
986.77M
986.77M – 986.77M
+67.0% YoY
|
620.21M
620.21M – 620.21M
-37.1% YoY
|
676.03M
676.03M – 676.03M
+9.0% YoY
|
| EBIT |
597.74M
est: 478.22M (+25.0%)
|
938.06M
est: 435.50M (+115.4%)
|
1.05B
est: 727.25M (+44.1%)
|
699.65M
est: 457.10M (+53.1%)
|
1.26B
est: 498.24M (+152.1%)
|
904.20M
est: 807.58M (+12.0%)
|
80.20M
est: 565.55M (-85.8%)
|
478.22M
478.22M – 478.22M
-15.4% YoY
|
435.50M
435.50M – 435.50M
-8.9% YoY
|
727.25M
727.25M – 727.25M
+67.0% YoY
|
457.10M
457.10M – 457.10M
-37.1% YoY
|
498.24M
498.24M – 498.24M
+9.0% YoY
|
| Net Income |
532.27M
est: 518.93M (+2.6%)
|
830.05M
est: 845.60M (-1.8%)
|
918.24M
est: 873.60M (+5.1%)
|
744.11M
est: 888.16M (-16.2%)
|
1.07B
est: 980.56M (+9.1%)
|
831.90M
est: 861.98M (-3.5%)
|
64.00M
est: 2.61B (-97.5%)
|
518.93M
518.93M – 518.93M
-80.1% YoY
|
845.60M
845.60M – 845.60M
+62.9% YoY
|
873.60M
873.60M – 873.60M
+3.3% YoY
|
888.16M
888.16M – 888.16M
+1.7% YoY
|
980.56M
980.56M – 980.56M
+10.4% YoY
|
| SGA |
363.85M
est: 1.19B (-69.4%)
|
391.61M
est: 1.41B (-72.3%)
|
371.32M
est: 1.81B (-79.5%)
|
426.49M
est: 1.14B (-62.5%)
|
334.60M
est: 1.24B (-73.0%)
|
438.20M
est: 2.08B (-78.9%)
|
1.91B
est: 1.83B (+3.9%)
|
1.19B
1.19B – 1.19B
-35.1% YoY
|
1.08B
1.08B – 1.08B
-8.9% YoY
|
1.81B
1.81B – 1.81B
+67.0% YoY
|
1.14B
1.14B – 1.14B
-37.1% YoY
|
1.24B
1.24B – 1.24B
+9.0% YoY
|
| EPS |
7.60
est: 9.27 (-18.0%)
|
11.82
est: 15.10 (-21.7%)
|
13.03
est: 15.60 (-16.5%)
|
11.34
est: 15.86 (-28.5%)
|
16.66
est: 17.51 (-4.9%)
|
14.01
est: 28.51 (-50.9%)
|
1.14
est: 46.41 (-97.5%)
|
9.27
9.27 – 9.27
-80.0% YoY
|
15.10
15.10 – 15.10
+62.9% YoY
|
15.60
15.60 – 15.60
+3.3% YoY
|
15.86
15.86 – 15.86
+1.7% YoY
|
17.51
17.51 – 17.51
+10.4% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-25 | B- | 2/5 | 3/5 | 1/5 | 1/5 | 4/5 | 1/5 | 4/5 |
| 2026-05-22 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-21 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-20 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-19 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-18 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-15 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-14 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-13 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-12 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-11 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-08 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-07 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-06 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-05 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-04 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-30 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-29 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-28 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-27 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-24 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-23 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-22 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-21 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-20 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-17 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-16 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Kailash Sahebrao Katkar | Co-Founder, Chairman of the Board & MD | 17M | — |
| Sanjay Sahebrao Katkar | Co-Founder, Joint MD & Director | 17M | — |
| Ashish Pradhan | Chief Technology Officer | — | male |
| Deepak Mishra | Head of Retail Sales | — | male |
| Lalit Mohan Sanagavarapu | Chief Product Officer | — | — |
| Sarang Deshpande | Company Secretary | — | male |
| Savita Nehra | Vice President of People & Culture | — | female |
| Sudhanshu Tripathi | Chief Marketing Officer | — | male |
| Ankit Maheshwari | Chief Financial Officer | — | male |
| Vikram Bharat Dhanani | Compliance Officer | — | male |
| Anupama Katkar | Chief of Operational Excellence & Chairperson of Quick Heal Foundation | — | female |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for QUICKHEAL.NS
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
